Western History Collection

- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ou.edu
Clinical Trials
394
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (328 trials with phase data)β’ Click on a phase to view related trials
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
- Conditions
- Cigar SmokingTobacco Use
- First Posted Date
- 2025-09-09
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 300
- Registration Number
- NCT07162935
- Locations
- πΊπΈ
West Virginia University, Morgantown, West Virginia, United States
Feasibility Study for Repurposing RET Inhibitors
- Conditions
- Cachexia-Anorexia Syndrome
- Interventions
- Other: Strength Assessment
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 7
- Registration Number
- NCT07146893
- Locations
- πΊπΈ
OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Improving Rates of Diagnostic Colonoscopy in Native Americans
- Conditions
- CRC ScreeningCRC (Colorectal Cancer)
- First Posted Date
- 2025-08-11
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 164
- Registration Number
- NCT07115875
- Locations
- πΊπΈ
TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
- Conditions
- Smoking Cessation
- Interventions
- Drug: Varenicline (VAR)Drug: Nicotine lozenge (NRT)Behavioral: Smartphone intervention with adherence components (ADHERE)Behavioral: Telephone CounselingBehavioral: Smartphone intervention without adherence components (NO ADHERE)
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 496
- Registration Number
- NCT07099638
- Locations
- πΊπΈ
TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
- Conditions
- Smoking Cessation InterventionPainSmoking (Tobacco) Addiction
- First Posted Date
- 2025-07-23
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 150
- Registration Number
- NCT07080788
- Locations
- πΊπΈ
University of Oklahoma - Schusterman Center, Tulsa, Oklahoma, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 79
- Next
News
University of Oklahoma Researchers Unlock Amylin Receptor Mechanisms for Next-Generation Obesity Drugs
University of Oklahoma researchers published breakthrough findings in Science Signaling revealing new understanding of how amylin receptors function, providing crucial insights for obesity drug development.
Smart-T Smoking Cessation App Shows Nearly Double Quit Rates in Low-Income Adults
University of Oklahoma researchers developed Smart-T, a real-time adaptive smartphone app that nearly doubled smoking cessation rates compared to a static app in a clinical trial of 454 low-income smokers.
Novel Hafnium-Based Treatment Trial Launches for Cisplatin-Ineligible Head and Neck Cancer Patients
International researchers launch NANORAY-312 trial investigating hafnium metal therapy combined with radiation as a novel treatment approach for head and neck cancer patients unsuitable for cisplatin treatment.